270 related articles for article (PubMed ID: 25426232)
1. The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.
O'Connor W; Quintana M; Smith S; Willis M; Renner J
J Radiol Case Rep; 2014 Jun; 8(6):27-38. PubMed ID: 25426232
[TBL] [Abstract][Full Text] [Related]
2. A case of giant cell tumor of sacrum with unusual pulmonary metastases: CT and FDG PET findings.
Zhang Y; Reeve IP; Lewis DH
Clin Nucl Med; 2012 Sep; 37(9):920-1. PubMed ID: 22889794
[TBL] [Abstract][Full Text] [Related]
3. Multimodality Imaging Features of a Misleading Sacral Giant Cell Tumor in 18F-FDG PET/CT, Bone Scan, and MRI.
Dejust S; Jallerat P; Soibinet-Oudot P; Jouannaud C; Morland D
Clin Nucl Med; 2020 Oct; 45(10):800-801. PubMed ID: 32604109
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
[TBL] [Abstract][Full Text] [Related]
5. Giant Cell Tumor of the Tendon Sheath With Discordant Metabolism as a False Positive on Staging of Mantle Cell Lymphoma.
Rezaee A; Chen W; Dilsizian V; Chen Q; Kimball AS
Clin Nucl Med; 2015 Oct; 40(10):814-5. PubMed ID: 26053722
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.
Albano D; Bosio G; Treglia G; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):77-84. PubMed ID: 28822997
[TBL] [Abstract][Full Text] [Related]
7. Disseminated osteomyelitis or bone metastases of breast cancer: (18)F-FDG-PET/CT helps unravel an unusual presentation.
Mandegaran R; Debard A; Alvarez M; Marchou B; Massip P; Wagner T
Ann Nucl Med; 2014 Feb; 28(2):167-71. PubMed ID: 24203488
[TBL] [Abstract][Full Text] [Related]
8. Giant cell tumor of tarsal bones. Report of three cases and review of the literature.
Mechlin MB; Kricun ME; Stead J; Schwamm HA
Skeletal Radiol; 1984; 11(4):266-70. PubMed ID: 6729499
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
Gedik GK; Ata O; Karabagli P; Sari O
Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
[TBL] [Abstract][Full Text] [Related]
10. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound - fine needle aspiration of 2-deoxy-2-[18F] fluoro-D-glucose avid lymph nodes seen on positron emission tomography- computed tomography -what looks like cancer may not always be so.
Malik AI; Akhtar N; Loya A; Yusuf MA
Cancer Imaging; 2014 Jul; 14(1):27. PubMed ID: 25608976
[TBL] [Abstract][Full Text] [Related]
12. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
13. Increased 18F FDG uptake in an unusual localization of giant cell tumor of the tendon sheath.
Demir Y; Unek IT; Tuncel AS; Karatosun V; Ozkal S; Kaya GC
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):205-6. PubMed ID: 22824209
[No Abstract] [Full Text] [Related]
14. FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series.
Koolen BB; Vegt E; Rutgers EJ; Vogel WV; Stokkel MP; Hoefnagel CA; Fioole-Bruining A; Vrancken Peeters MJ; Valdés Olmos RA
Ann Nucl Med; 2012 Jan; 26(1):86-91. PubMed ID: 21953212
[TBL] [Abstract][Full Text] [Related]
15. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
[TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT of primary bone tumors.
Costelloe CM; Chuang HH; Madewell JE
AJR Am J Roentgenol; 2014 Jun; 202(6):W521-31. PubMed ID: 24848845
[TBL] [Abstract][Full Text] [Related]
17. FDG uptake in giant cell tumor of the tendon sheath in a patient restaged for gastrointestinal stroma tumor (GIST).
Wissmeyer M; Kohl S; Juengling FD; Stauffer E; Siebenrock KA; Krause TM
Clin Nucl Med; 2009 Mar; 34(3):193-6. PubMed ID: 19352292
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of in situ, high-resolution correlation of tracer uptake with histopathology by quantitative autoradiography of biopsy specimens obtained under 18F-FDG PET/CT guidance.
Fanchon LM; Dogan S; Moreira AL; Carlin SA; Schmidtlein CR; Yorke E; Apte AP; Burger IA; Durack JC; Erinjeri JP; Maybody M; Schöder H; Siegelbaum RH; Sofocleous CT; Deasy JO; Solomon SB; Humm JL; Kirov AS
J Nucl Med; 2015 Apr; 56(4):538-44. PubMed ID: 25722446
[TBL] [Abstract][Full Text] [Related]
19. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
[TBL] [Abstract][Full Text] [Related]
20. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
